Trials / Completed
CompletedNCT03179813
Topical Hydrocortisone for Pain and Edema Control After Third Molar Surgery
Topical Hydrocortisone for Pain and Edema Control After Third Molar Surgery: a Clinical, Crossover, Randomized, Double-blind, Controlled Study
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 40 (estimated)
- Sponsor
- University of Sao Paulo · Academic / Other
- Sex
- All
- Age
- 14 Years
- Healthy volunteers
- Accepted
Summary
The investigators set out to develop a clinical trial in order to test the topical use of hydrocortisone as a intraoperative irrigant solution. As this route of administration as well as being low cost and not add new steps to the surgical procedure, can contribute to an improved quality of life in the postoperative period of patients undergoing extraction of third molars.
Detailed description
Third molars are the teeth with a higher prevalence of failure in eruption and surgery for extraction of these impacted teeth is one of the most commonly procedures performed by the oral and maxillofacial surgeon. In most cases these are not traumatic procedures, however factors such as patient age, habits, degree of tooth impaction and surgeon experience can influence the surgical trauma and therefore the postoperative period could include swelling and pain of varying magnitudes which can significantly affect the patient's quality of life. The study is designed as a prospective, randomized, placebo-controlled, split-mouth crossover trial. All the patients will be informed of the experimental methodology and signed a institutionally approved consent form. The study is been conducted in compliance with Declaration of Helsinki (1989), and was revised by the Institutional Ethical Committee (protocol 1.167.908).
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | Hydrocortisone | During the third molar extraction the hydrocortisone solution will be used in the test group |
| PROCEDURE | Control | During the third molar extraction the saline solution will be used in the control group |
Timeline
- Start date
- 2017-05-01
- Primary completion
- 2018-01-03
- Completion
- 2018-03-01
- First posted
- 2017-06-07
- Last updated
- 2018-03-07
Locations
1 site across 1 country: Brazil
Source: ClinicalTrials.gov record NCT03179813. Inclusion in this directory is not an endorsement.